Published in Crit Care on December 14, 2004
Midazolam administration reverses thermal hyperalgesia and prevents gamma-aminobutyric acid transporter loss in a rodent model of neuropathic pain. Anesth Analg (2008) 0.84
Effect of an analgo-sedation protocol for neurointensive patients: a two-phase interventional non-randomized pilot study. Crit Care (2010) 0.81
Between benzodiazepine over-sedation and neurological damage. Crit Care (2005) 0.75
Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med (2002) 9.74
Reversal of midazolam sedation with flumazenil. Crit Care Med (1992) 2.24
Clinical pharmacokinetics of fentanyl and its newer derivatives. Clin Pharmacokinet (1983) 1.45
Prolonged sedation due to accumulation of conjugated metabolites of midazolam. Lancet (1995) 1.35
Clinical pharmacokinetics of midazolam in intensive care patients, a wide interpatient variability? Clin Pharmacol Ther (1988) 1.24
Possibility of influence of midazolam sedation on the diagnosis of brain death: concentrations of active metabolites after cessation of midazolam. Yakugaku Zasshi (2003) 1.04
The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients. Clin Pharmacokinet (1988) 1.02
Flumazenil--treatment or toxin. J Toxicol Clin Toxicol (2004) 0.92
Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science (2003) 4.80
Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet (2003) 3.44
The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat Immunol (2010) 2.55
Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications. J Exp Med (2003) 2.19
IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity (2008) 1.83
Doxorubicin eluting beads - 1: effects of drug loading on bead characteristics and drug distribution. J Mater Sci Mater Med (2007) 1.79
Worldwide food recall patterns over an eleven month period: a country perspective. BMC Public Health (2008) 1.55
Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency. Clin Immunol (2004) 1.51
Anti-collagenase, anti-elastase and anti-oxidant activities of extracts from 21 plants. BMC Complement Altern Med (2009) 1.45
Circulating anions usually associated with the Krebs cycle in patients with metabolic acidosis. Crit Care (2005) 1.44
Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis. Blood (2005) 1.41
Doxorubicin eluting beads-2: methods for evaluating drug elution and in-vitro:in-vivo correlation. J Mater Sci Mater Med (2007) 1.33
Vitamin D in health and disease: current perspectives. Nutr J (2010) 1.31
International variation in ethics committee requirements: comparisons across five Westernised nations. BMC Med Ethics (2002) 1.26
Site specific mutation of the Zic2 locus by microinjection of TALEN mRNA in mouse CD1, C3H and C57BL/6J oocytes. PLoS One (2013) 1.26
Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience. Blood (2011) 1.24
The study of reproductive outcome and the health of offspring of UK veterans of the Gulf war: methods and description of the study population. BMC Public Health (2003) 1.16
Complimentary and alternative medicine use among patients starting warfarin. Br J Haematol (2005) 1.14
Subtle differences in CTL cytotoxicity determine susceptibility to hemophagocytic lymphohistiocytosis in mice and humans with Chediak-Higashi syndrome. Blood (2011) 1.12
Performance enhancement with supplements: incongruence between rationale and practice. J Int Soc Sports Nutr (2007) 1.10
Determination of metal ion content of beverages and estimation of target hazard quotients: a comparative study. Chem Cent J (2008) 1.09
Hematopoietic stem cell transplantation for complete IFN-gamma receptor 1 deficiency: a multi-institutional survey. J Pediatr (2004) 1.09
Virtue or pretense? Looking behind self-declared innocence in doping. PLoS One (2010) 1.08
Vitamin D deficiency during pregnancy: confronting the issues. Clin Endocrinol (Oxf) (2013) 1.07
Miscarriage, stillbirth and congenital malformation in the offspring of UK veterans of the first Gulf war. Int J Epidemiol (2004) 1.05
Misleading measures in Vitamin D analysis: a novel LC-MS/MS assay to account for epimers and isobars. Nutr J (2011) 1.05
Increased plasma chymase concentration and mast cell chymase expression in venous neointimal lesions of patients with CKD and ESRD. Semin Dial (2011) 1.02
Nutritional supplement use by elite young UK athletes: fallacies of advice regarding efficacy. J Int Soc Sports Nutr (2008) 1.02
Iron supplements: the quick fix with long-term consequences. Nutr J (2004) 1.02
Comfort in big numbers: Does over-estimation of doping prevalence in others indicate self-involvement? J Occup Med Toxicol (2008) 1.02
Analysis of anabolic steroids in human hair using LC-MS/MS. Steroids (2010) 1.01
Supplement use in sport: is there a potentially dangerous incongruence between rationale and practice? J Occup Med Toxicol (2007) 1.01
Incongruence in doping related attitudes, beliefs and opinions in the context of discordant behavioural data: in which measure do we trust? PLoS One (2011) 1.01
Management of sodium disorders during continuous haemofiltration. Crit Care (2010) 1.00
Use of oral clonidine for sedation in ventilated paediatric intensive care patients. Intensive Care Med (2004) 0.97
An observational study reveals that neonatal vitamin D is primarily determined by maternal contributions: implications of a new assay on the roles of vitamin D forms. Nutr J (2013) 0.97
The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2. Blood (2013) 0.97
Immune reconstitution and recovery of FOXP3 (forkhead box P3)-expressing T cells after transplantation for IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome. Pediatrics (2008) 0.96
Heparin algorithm for anticoagulation during continuous renal replacement therapy. Crit Care (2010) 0.96
Broad-range polymerase chain reaction for the diagnosis of Bartonella henselae endocarditis. J Paediatr Child Health (2006) 0.95
Inhalation toxicology of ricin preparations: animal models, prophylactic and therapeutic approaches to protection. Inhal Toxicol (2007) 0.95
The age-gender-status profile of high performing athletes in the UK taking nutritional supplements: lessons for the future. J Int Soc Sports Nutr (2008) 0.95
New non-randomised model to assess the prevalence of discriminating behaviour: a pilot study on mephedrone. Subst Abuse Treat Prev Policy (2011) 0.94
Material properties and composition of soft-tissue fixation. Arthroscopy (2010) 0.93
Red wine and component flavonoids inhibit UGT2B17 in vitro. Nutr J (2012) 0.93
Limited agreement exists between rationale and practice in athletes' supplement use for maintenance of health: a retrospective study. Nutr J (2007) 0.93
Insertional mutagenesis of ricin A chain: a novel route to an anti-ricin vaccine. Vaccine (2004) 0.92
Potentially fatal new trend in performance enhancement: a cautionary note on nitrite. J Int Soc Sports Nutr (2010) 0.92
Therapeutic chelators for the twenty first century: new treatments for iron and copper mediated inflammatory and neurological disorders. Curr Drug Deliv (2005) 0.91
Anti-microbial activities of pomegranate rind extracts: enhancement by cupric sulphate against clinical isolates of S. aureus, MRSA and PVL positive CA-MSSA. BMC Complement Altern Med (2009) 0.91
Dietary green and white teas suppress UDP-glucuronosyltransferase UGT2B17 mediated testosterone glucuronidation. Steroids (2012) 0.91
Early experiences of the mini-PAT (Peer Assessment Tool) amongst hospital pharmacists in south east London. Int J Pharm Pract (2009) 0.90
Superoxide and hydrogen peroxide suppression by metal ions and their EDTA complexes. Biochem Biophys Res Commun (2004) 0.90
Ouabain, a circulating hormone secreted by the adrenals, is pivotal in cardiovascular disease. Fact or fantasy? J Hypertens (2009) 0.90
Comparison of DC Bead-irinotecan and DC Bead-topotecan drug eluting beads for use in locoregional drug delivery to treat pancreatic cancer. J Mater Sci Mater Med (2010) 0.89
Information about medicines to cardiac in-patients: patient satisfaction alongside the role perceptions and practices of doctors, nurses and pharmacists. Patient Educ Couns (2011) 0.89
Inside athletes' minds: preliminary results from a pilot study on mental representation of doping and potential implications for anti-doping. Subst Abuse Treat Prev Policy (2011) 0.88
Antimicrobial activities of pomegranate rind extracts: enhancement by addition of metal salts and vitamin C. BMC Complement Altern Med (2008) 0.86
In vitro changes in human tenocyte cultures obtained from proximal biceps tendon: multiple passages result in changes in routine cell markers. Knee Surg Sports Traumatol Arthrosc (2011) 0.86
Characterisation of physico-mechanical properties and degradation potential of calcium alginate beads for use in embolisation. J Mater Sci Mater Med (2010) 0.86
Method for simultaneous analysis of eight analogues of vitamin D using liquid chromatography tandem mass spectrometry. Chem Cent J (2012) 0.86
Food alert patterns for metal contamination analyses in seafoods: longitudinal and geographical perspectives. Environ Int (2009) 0.86
Assessing the in vitro biocompatibility of a novel carbon device for the treatment of sepsis. Biomaterials (2005) 0.85
Effects of Dietary Components on Testosterone Metabolism via UDP-Glucuronosyltransferase. Front Endocrinol (Lausanne) (2013) 0.85
Catalytic superoxide scavenging by metal complexes of the calcium chelator EGTA and contrast agent EHPG. Biochem Biophys Res Commun (2004) 0.84
An investigation of the relationship between the anti-inflammatory activity, polyphenolic content, and antioxidant activities of cooked and in vitro digested culinary herbs. Oxid Med Cell Longev (2012) 0.84
Lipophilic ionophore complexes as superoxide dismutase mimetics. Biochem Biophys Res Commun (2005) 0.83
Network analytical tool for monitoring global food safety highlights China. PLoS One (2009) 0.83
Understanding how adherence goals promote adherence behaviours: a repeated measure observational study with HIV seropositive patients. BMC Public Health (2012) 0.83
The in vitro adsorption of cytokines by polymer-pyrolysed carbon. Biomaterials (2006) 0.82
Inflammatory cytokine removal by an activated carbon device in a flowing system. Biomaterials (2008) 0.82
Novel biocompatible phosphorylcholine-based self-assembled nanoparticles for drug delivery. J Control Release (2005) 0.82
An adsorbent monolith device to augment the removal of uraemic toxins during haemodialysis. J Mater Sci Mater Med (2014) 0.82
Cardiac Troponin Release is Associated with Biomarkers of Inflammation and Ventricular Dilatation During Critical Illness. Shock (2016) 0.81
Dietary chelators as antioxidant enzyme mimetics: implications for dietary intervention in neurodegenerative diseases. Behav Pharmacol (2006) 0.81
Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids. Subst Abuse Treat Prev Policy (2010) 0.81
Chemical changes in aging Drosophila melanogaster. Age (Dordr) (2009) 0.81
Development and validation of the Medication-Related Consultation Framework (MRCF). Patient Educ Couns (2011) 0.81
A systematic review on the herbal extract Tribulus terrestris and the roots of its putative aphrodisiac and performance enhancing effect. J Diet Suppl (2014) 0.81
Unmeasured anions in metabolic acidosis: unravelling the mystery. Crit Care (2006) 0.81
HIV Patient Characteristics that Affect Adherence to Exercise Programmes: An Observational Study. Open AIDS J (2010) 0.81
Mesoporous carbide-derived carbon with porosity tuned for efficient adsorption of cytokines. Biomaterials (2006) 0.81
Antioxidant enzymatic activities in Alzheimer's disease: the relationship to acetylcholinesterase inhibitors. J Alzheimers Dis (2012) 0.80
Reduction of paraquat-induced renal cytotoxicity by manganese and copper complexes of EGTA and EHPG. Free Radic Biol Med (2007) 0.80
Management of acute renal failure on the intensive care unit. Clin Med (2002) 0.80
Circulating sodium pump inhibitors in five volume-expanded humans. J Hypertens (2003) 0.80
Simultaneous analysis of antiretroviral drugs abacavir and tenofovir in human hair by liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal (2012) 0.80
Exploring the role of vitamin D in type 1 diabetes, rheumatoid arthritis, and Alzheimer disease: new insights from accurate analysis of 10 forms. J Clin Endocrinol Metab (2014) 0.80
Boronate-containing polymer brushes: characterization, interaction with saccharides and mammalian cancer cells. J Biomed Mater Res A (2009) 0.80
Adsorption of anionic and cationic dyes by activated carbons, PVA hydrogels, and PVA/AC composite. J Colloid Interface Sci (2011) 0.80
Promoting functional foods as acceptable alternatives to doping: potential for information-based social marketing approach. J Int Soc Sports Nutr (2010) 0.79
Improving the interface between family planning services and genitourinary medicine in Portsmouth, UK: a 'virtual corridor'. J Fam Plann Reprod Health Care (2007) 0.79
Activation-dependent adsorption of cytokines and toxins related to liver failure to carbon beads. Biomacromolecules (2011) 0.79
Antioxidant and potential anti-inflammatory activity of extracts and formulations of white tea, rose, and witch hazel on primary human dermal fibroblast cells. J Inflamm (Lond) (2011) 0.79
Development of a combination drug-eluting bead: towards enhanced efficacy for locoregional tumour therapies. Anticancer Drugs (2012) 0.78
A rapid LC-MS method for determination of plasma anion profiles of acidotic patients. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.78